Early-Stage Innovation (Incubation, Early Innovation Partnerships, JJDC Venture Capital)

About this program

Johnson & Johnson Innovation — through JLABS incubators, JJDC venture capital and targeted QuickFire/partnership challenges — provides early-stage support including incubation space, strategic collaborations, prize awards and direct investments to accelerate translational healthcare, MedTech and innovative medicine projects toward clinical and commercial development. Funding and resources are delivered via multiple mechanisms (JLABS residency, JJDC investments, and challenge/partnership awards) with access to J&J’s global innovation centers and technical expertise. Applicants should be early-stage startups, academic teams or spinouts with novel therapeutic, diagnostic or device technologies aligned to J&J’s focus areas, presenting clear translational potential, supporting data or IP, and a realistic development plan. Programs are global but selection prioritizes projects with scalable clinical/commercial pathways and fit with J&J’s strategic priorities; specific eligibility and application processes vary by program.